Apelin protects sarcoplasmic reticulum function and cardiac performance in ischaemia-reperfusion by attenuating oxidation of sarcoplasmic reticulum Ca 21-ATPase and ryanodine receptor

Cardiovascular Research

Volumn 100, Issue 1, 2013, Pages 114-124

  Wang, Chen ^a   Liu, Nan ^a   Luan, Ronghua ^a   Li, Yan ^a   Wang, Dongjuan ^a   Zou, Wei ^a   Xing, Ying ^a   Tao, Ling ^a   Cao, Feng ^a   Wang, Haichang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Ca2+; Ischaemic contracture; PI3K; PKC; ROS

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); APELIN; LACTATE DEHYDROGENASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; RYANODINE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; DIASTOLIC BLOOD PRESSURE; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE SYSTOLIC PRESSURE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PERFORMANCE; MALE; NONHUMAN; OXIDATION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION; SARCOPLASMIC RETICULUM; SURVIVAL;

CA2+; ISCHAEMIC CONTRACTURE; PI3K; PKC; ROS;

ANIMALS; CALCIUM; GLUTATHIONE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; L-LACTATE DEHYDROGENASE; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SIGNAL TRANSDUCTION;

EID: 84887897992     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt160     Document Type: Article

References (48)

1. O'Dowd B.F., Heiber M, Chan A., Heng HH, Tsui LC, Kennedy JL et al. Ahuman gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 1993; 136: 355-360.
2. Tatemoto K, Hosoya M, Habata Y., Fujii R, Kakegawa T, Zou MX et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998; 251: 471-476.
3. Kleinz MJ, Davenport AP. Emerging roles of apelin in biology and medicine. Pharmacol Ther 2005; 107: 198-211.
4. Tatemoto K, Takayama K, Zou M.X., Kumaki I., Zhang W, Kumano K et al. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 2001; 99: 87-92.
5. Szokodi I, Tavi P, Foldes G., Voutilainen-Myllyla S, Ilves M, Tokola H et al. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 2002; 91: 434-440.
6. Kleinz MJ, Baxter GF. Apelin reduces myocardial reperfusion injury independently of PI3K/Akt and P70S6 kinase. Regul Pept 2008; 146: 271-277.
7. Simpkin JC, Yellon DM, Davidson S.M., Lim SY, Wynne AM, Smith CC. Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury. Basic Res Cardiol 2007; 102: 518-528.
8. Zeng XJ, Zhang LK, Wang H.X., Lu LQ, Ma LQ, Tang CS. Apelin protects heart against ischemia/reperfusion injury in rat. Peptides 2009; 30: 1144-1152.
9. Rastaldo R, Cappello S, Folino A., Berta GN, Sprio AE, Losano G et al. Apelin-13 limits infarct size and improves cardiac postischemic mechanical recovery only if given after ischemia. Am J Physiol Heart Circ Physiol 2011; 300:H2308-H2315.
10. Tao J, Zhu W, Li Y., Xin P, Li J, Liu M et al. Apelin-13 protects the heart against ischemia-reperfusion injury through inhibition of ER-dependent apoptotic pathways in a time-dependent fashion. Am J Physiol Heart Circ Physiol 2011; 301:H1471-H1486.
11. Dhalla NS, Panagia V, Singal P.K., Makino N., Dixon IM, Eyolfson DA. Alterations in heart membrane calcium transport during the development of ischemia-reperfusion injury. J Mol Cell Cardiol 1988; 20(Suppl. 2): 3-13.
12. Feher JJ, LeBolt WR, Manson NH. Differential effect of global ischemiaonthe ryanodine-sensitive and ryanodine-insensitive calcium uptake of cardiac sarcoplasmic reticulum. Circ Res 1989; 65: 1400-1408.
13. Temsah RM, Netticadan T, Chapman D., Takeda S, Mochizuki S, Dhalla NS. Alterations in sarcoplasmic reticulum function and gene expression in ischemic-reperfused rat heart. Am J Physiol 1999; 277:H584-H594.
14. Nayler WG. The significance of calcium ions in cardiac excitation and contraction. Am Heart J 1963; 65: 404-411.
15. Zweier JL. Measurementofsuperoxide-derived free radicals inthe reperfused heart. Evidence for a free radical mechanism of reperfusion injury. J Biol Chem 1988; 263: 1353-1357.
16. Zima AV, Blatter LA. Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res 2006; 71: 310-321.
17. Burton KP, McCord JM, Ghai G. Myocardial alterations due to free-radical generation. Am J Physiol 1984; 246:H776-H783.
18. Blaustein AS, Schine L, Brooks W.W., Fanburg BL, Bing OH. Influence of exogenously generated oxidant species on myocardial function. Am J Physiol 1986; 250:H595-H599.
19. Rowe GT, Manson NH, Caplan M, Hess ML. Hydrogen peroxide and hydroxyl radical mediation of activated leukocyte depression of cardiac sarcoplasmic reticulum. Participation of the cyclooxygenase pathway. Circ Res 1983; 53: 584-591.
20. 2+-pump activity by oxygen free radicals. Am J Physiol 1989; 256:H368-H374.
21. 2+]i transient and contractions during twitches in isolated rat cardiac myocytes. Am J Physiol Heart Circ Physiol 2008; 294:H2540-H2546.
22. Zatta AJ, Kin H, Lee G., Wang N, Jiang R, Lust R et al. Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling. Cardiovasc Res 2006; 70: 315-324.
23. Vinten-Johansen J., Granfeldt A, Mykytenko J., Undyala VV, Dong Y, Przyklenk K. The multidimensional physiological responses to postconditioning. Antioxid Redox Signal 2011; 14: 791-810.
24. Pei H, Qu Y, Lu X., Yu Q, Lian K, Liu P et al. Cardiac-derived adiponectin induced by longterm insulin treatment ameliorates myocardial ischemia/reperfusion injury in type 1 diabetic mice via AMPK signaling. Basic Res Cardiol 2013; 108: 322.
25. Ganguly PK, Pierce GN, Dhalla K.S., Dhalla NS. Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol 1983; 244:E528-E535.
26. 2+ channels. Circ Res 1994; 74: 271-280.
27. Zucchi R, Cerniway RJ, Ronca-Testoni S, Morrison R.R., Ronca G., Matherne GP. Effect of cardiac A(1) adenosine receptor overexpression on sarcoplasmic reticulum function. Cardiovasc Res 2002; 53: 326-333.
28. Luan R, Liu S, Yin T., Lau WB, Wang Q, Guo W et al. High glucose sensitizes adult cardi-omyocytes to ischaemia/reperfusion injury through nitrative thioredoxin inactivation. Cardiovasc Res 2009; 83: 294-302.
29. Tang WH, Kravtsov GM, Sauert M, Tong X.Y., Hou XY, Wong TM et al. Polyol pathway impairs the function of SERCA and RyR in ischemic-reperfused rat hearts by increasing oxidative modifications of these proteins. J Mol Cell Cardiol 2010; 49: 58-69.
30. Stokke MK, Briston SJ, Jolle G.F., Manzoor I., Louch WE, Oyehaug L et al. Ca(2+) wave probability is determined by the balance between SERCA2-dependent Ca(2+) re-uptake and threshold SR Ca(2+) content. Cardiovasc Res 2011; 90: 503-512.
31. Gao WD, Liu Y, Marban E. Selective effects of oxygen free radicals on excitation-contraction coupling in ventricular muscle. Implications for the mechanism of stunned myocardium. Circulation 1996; 94: 2597-2604.
32. Katz AM, Tada M. The 'stone heart': a challenge to the biochemist. Am J Cardiol 1972; 29: 578-580.
33. Pisarenko OI, Shulzhenko VS, Pelogeikina IuA, Studneva IM, Kkhatri DN, Bespalova ZhD et al. Effects of exogenous apelin-12 on functional and metabolic recovery of isolated rat heart after ischemia. Kardiologiia 2010; 50: 44-49.
34. 2 modulate superoxide anion production in bovine cardiac myocytes: potential role of NADH oxidase. Circulation 1997; 96: 614-620.
35. Xu KY, Zweier JL, Becker LC. Hydroxyl radical inhibits sarcoplasmic reticulum Ca(2+)-ATPase function by direct attack on the ATP binding site. Circ Res 1997; 80: 76-81.
36. Lattanzio FA Jr, Schlatterer RG, Nicar M, Campbell K.P., Sutko JL. The effectsofryanodine on passive calcium fluxes across sarcoplasmic reticulum membranes. J Biol Chem 1987; 262: 2711-2718.
37. 2+ release channel of sarco-plasmic reticulum. J Biol Chem 1986; 261: 6300-6306.
38. 2+ release channel. Am J Physiol 1987; 253:C364-C368.
39. Zima AV, Copello JA, Blatter LA. Effects of cytosolic NADH/NAD(+) levels on sarco-plasmic reticulum Ca(2+) release in permeabilized rat ventricular myocytes. J Physiol 2004; 555: 727-741.
40. Aracena P, Tang W, Hamilton S.L., Hidalgo C. Effects of S-glutathionylation and S-nitrosylation on calmodulin binding to triads and FKBP12 binding to type 1 calcium release channels. Antioxid Redox Signal 2005; 7: 870-881.
41. Sanchez G, Pedrozo Z, Domenech R.J., Hidalgo C., Donoso P. Tachycardia increases NADPH oxidase activity and RyR2 S-glutathionylation in ventricular muscle. J Mol Cell Cardiol 2005; 39: 982-991.
42. Cohen MV, Downey JM. Ischemic postconditioning: from receptorto end-effector. Antioxid Redox Signal 2011; 14: 821-831.
43. Penna C, Mancardi D, Raimondo S., Geuna S, Pagliaro P. The paradigm of postconditioning to protect the heart. J Cell Mol Med 2008; 12: 435-458.
44. Zhu S, Sun F, Li W., Cao Y, Wang C, Wang Y et al. Apelin stimulates glucose uptake through the PI3K/Akt pathway and improves insulin resistance in 3T3-L1 adipocytes. Mol Cell Biochem 2011; 353: 305-313.
45. Shinmura K, Nagai M, Tamaki K., Bolli R. Loss of ischaemic preconditioning in ovariecto-mized rat hearts: possible involvement of impaired protein kinase C epsilon phosphorylation. Cardiovasc Res 2008; 79: 387-394.
46. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 2008; 88: 581-609.
47. Costa AD, Pierre SV, Cohen M.V., Downey JM, Garlid KD. cGMP signalling in pre- and post-conditioning: the role of mitochondria. Cardiovasc Res 2008; 77: 344-352.
48. Zhao ZQ, Vinten-Johansen J. Postconditioning: reduction of reperfusion-induced injury. Cardiovasc Res 2006; 70: 200-211.